Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | ITPR3 | Q14573 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL7582145 | 0.98 | SMPD1 (0.39) | SMPD1ADORA1ITPR3 | |
| SCHEMBL30007287 | 0.98 | SMPD1 (0.39) | SMPD1ADORA1ITPR3 | |
| SCHEMBL30360450 | 0.95 | P2RY14 (0.39) | — | |
| SCHEMBL4143599 | 0.89 | SMPD1 (0.47) | SMPD1ITPR3 | |
| SCHEMBL29656742 | 0.86 | P2RY14 (0.47) | — | |
| SCHEMBL3360274 | 0.86 | P2RY14 (0.47) | — | |
| SCHEMBL7541741 | 0.84 | P2RY14 (0.49) | — | |
| SCHEMBL7568898 | 0.84 | P2RY14 (0.49) | — | |
| SCHEMBL7568905 | 0.84 | P2RY14 (0.49) | — | |
| SCHEMBL7568791 | 0.84 | P2RY14 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1711 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| CN-122029287-A | Method for producing NMN and method for producing NAD | 东方酵母工业株式会社 | 2026-05-12 | — | — | CN | claimed |
| CN-121574893-A | Genetic engineering bacterium for catalyzing synthesis of cerulosa from cerulosa derivative, construction method and application thereof | 南京玖合生物科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4692364-A1 | METHOD FOR PRODUCING SUBSTANCE | Mitsubishi Chemical Corporation (JP) | 2026-02-11 | — | — | EP | claimed |
| US-20260028656-A1 | METHOD FOR PRODUCING SUBSTANCE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-29 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| US-12329726-B2 | Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-06-17 | — | — | US | claimed |
| CN-116064702-B | Method for producing nicotinamide mononucleotide | 旭化成制药株式会社 | 2025-06-10 | — | — | CN | claimed |
| WO-2025089354-A1 | METHOD FOR PRODUCING NMN AND METHOD FOR PRODUCING NAD | オリエンタル酵母工業株式会社 | 2025-05-01 | — | — | WO | claimed |
| US-7598031-B2 | Method for the detection of gene transcripts in blood and uses thereof | GENENEWS CORPORATION (CA) | 2009-10-06 | — | — | US | claimed |
| US-20090246803-A1 | NAD BIOSYNTHESIS SYSTEMS | WASHINGTON UNIVERSITY (US) | 2009-10-01 | — | — | US | claimed |
| WO-2009020596-A2 | EMBRYONIC CEREBROSPINAL FLUIS (E-CSF), PROTEINS FROM E-CSF, AND RELATED METHODS AND COMPOSITIONS | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2009-02-12 | — | — | WO | claimed |
| WO-2008043849-A2 | PLANTS WITH INCREASED YIELD | BASF PLANT SCIENCE GMBH (DE) | 2008-04-17 | — | — | WO | claimed |
| WO-2006041624-A2 | NAD BIOSYNTHESIS SYSTEMS | WASHINGTON UNIVERSITY (US) | 2006-04-20 | — | — | WO | claimed |
| CN-1361262-A | New polypeptide hypoxanthine phosphoribosyl pyrophosphate transferase 32.34 and polynucleotides encoding this polypeptide | BODE GENE DEV CO LTD SHANGHAI (CN) | 2002-07-31 | — | — | CN | claimed |
| US-6258554-B1 | SELECTING PARENT STRAIN FROM CORYNEBACTERIUM, BREVIBACTERIUM OR ESCHERICHIA HAVING TRANSKELOLASE ACTIVITY, REDUCING OR DEACTIVATING TRANSKETOLASE, AND THEN DECTECTING INCREASE IN PRODUCTIVITY OF PHOSPHORIBOSYL PYROPHOSPHATE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2001-07-10 | — | — | US | claimed |
| EP-0994952-A1 | PLANT ATP-PHOSPHORIBOSYL TRANSFERASE AND DNA CODING THEREFOR | Novartis AG (CH) | 2000-04-26 | — | — | EP | claimed |
| EP-0969096-A1 | Method for producing metabolites biologically synthesized via phosphoribosyl pyrophosphate | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 2000-01-05 | — | — | EP | claimed |
| WO-1999005286-A1 | PLANT ATP-PHOSPHORIBOSYL TRANSFERASE AND DNA CODING THEREFOR | NOVARTIS AG (CH) | 1999-02-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028656-A1 | METHOD FOR PRODUCING SUBSTANCE | NADK, NAMPT, PRPS1 | SMPD1 689/4885ADORA1 143/4885ITPR3 1087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.